Hyperkalaemia in Heart Failure
Hyperkalaemia has become an increasingly prevalent finding in patients with heart failure (HF), especially with renin–angiotensin–aldosterone system (RAAS) inhibitors and angiotensin–neprilysin inhibitors being the cornerstone of medical therapy. Patients living with HF often have other comorbiditie...
Guardado en:
Autores principales: | Umar Ismail, Kiran Sidhu, Shelley Zieroth |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9419a0cd11214729a55fb86549079483 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The New Heart Failure Association Definition of Advanced Heart Failure
por: Marco Metra, et al.
Publicado: (2019) -
Hidden in Heart Failure
por: Douglas Ewan Cannie, et al.
Publicado: (2019) -
Ultrafiltration in Acute Heart Failure
por: Maria Rosa Costanzo
Publicado: (2019) -
Telemonitoring in Heart Failure Management
por: Ivo Planinc, et al.
Publicado: (2020) -
Heart Failure Treatment by Device
por: Antoni Bayés-Genis
Publicado: (2020)